Skip to main content
Equibles

STATE STREET CORP

Position in DFTX — Definium Therapeutics, Inc.

CIK 93751 BOSTON, MA
Back to DFTX Full portfolio

Position in DFTX

as of Jun 30, 2026 · filed Sep 22, 2026
Position Value
$144,195,945
+$97,477,546 QoQ
Shares Held
3,065,390
+24.0% QoQ
Ownership
2.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
16 quarters on record
Voting authority Sole 24% Shared 0% None 76%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,949,192,558 across 423 Biotechnology names. DFTX ranks #63 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in DFTX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $144,195,945 3,065,390
2026-03-31 $46,718,399 2,471,873